Endothelin-1 overexpression improves renal function in eNOS knockout mice

Cellular Physiology and Biochemistry

Volumn 37, Issue 4, 2015, Pages 1474-1490

  Tsuprykov, Oleg ^a,b   Chaykovska, Lyubov ^c   Kretschmer, Axel ^d   Stasch, Johannes Peter ^d,e   Pfab, Thiemo ^b,j   Krause Relle, Katharina ^a,b   Reichetzeder, Christoph ^a,b   Kalk, Philipp ^f   Adamski, Jerzy ^g,h,i   Hocher, Berthold ^a,k  

^a UNIVERSITY OF POTSDAM   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d BAYER PHARMA AG   (Germany)

^e MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g INSTITUTE OF EPIDEMIOLOGY   (Germany)

^h TECHNICAL UNIVERSITY OF MUNICH   (Germany)

ⁱ GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^j Diaverum   (Germany)

^k IFLb Laboratoriumsmedizin Berlin GmbH   (Germany)

more..

Author keywords

Chronic kidney disease; Endothelial nitric oxide synthase; Endothelin; Mice; Nitric oxide

Indexed keywords

ACYLCARNITINE; ALBUMIN; AMINO ACID; BIOLOGICAL MARKER; CARNITINE; CYSTATIN C; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; FATTY ACID BINDING PROTEIN; HEXOSE; LYSOPHOSPHATIDYLCHOLINE; NITRIC OXIDE; OSTEOPONTIN; PHOSPHATIDYLCHOLINE; ALBUMINOID; COLLAGEN TYPE 1; COLLAGEN TYPE I, ALPHA 1 CHAIN; CONNECTIVE TISSUE GROWTH FACTOR; FABP3 PROTEIN, MOUSE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CCL2 GENE; COL1A1 GENE; CONTROLLED STUDY; EXCRETION; GENE; GENE EXPRESSION; GLOMERULAR FILTRATION BARRIER; GLOMERULOSCLEROSIS; HYPERTENSION; KIDNEY FIBROSIS; KIDNEY FUNCTION; MALE; METABOLOMICS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN URINE LEVEL; SERPINE1 GENE; SYSTOLIC BLOOD PRESSURE; TIMP1 GENE; UPREGULATION; URINARY EXCRETION; ANIMAL; BLOOD; BLOOD PRESSURE; DEFICIENCY; FEMALE; GENETICS; HUMAN; KIDNEY; KNOCKOUT MOUSE; METABOLISM; MITOCHONDRION; PATHOLOGY; TRANSGENIC MOUSE; URINE;

ALBUMINS; ANIMALS; BLOOD PRESSURE; CARNITINE; COLLAGEN TYPE I; CONNECTIVE TISSUE GROWTH FACTOR; CYSTATIN C; ENDOTHELIN-1; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; KIDNEY; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MITOCHONDRIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OSTEOPONTIN; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 84946781840     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000438516     Document Type: Article

References (52)

1. Slowinski T, Kalk P, Christian M, Schmager F, Relle K, Godes M, Funke-Kaiser H, Neumayer HH, Bauer C, TheuringF, HocherB. Cell-Dype specific interaction of endothelinandthe nitric oxide system: pattern of prepro-ET-1 expression in kidneys of L-NAME treated prepro-ET-1 promoter-lacZ-Dransgenic mice. ] Physiol 2007;581:1173-1181.
2. Quaschning T, Koçak S, Bauer C, Neumayer H-H, Galle J, Hocher B. Increase in nitric oxide bioavailability improves endothelial function in endothelin-1 transgenic mice. Nephrol Dial Transplant 2003;18:479-483.
3. Kohan DE, Pollock DM. Endothelin antagonists for diabetic and non-diabetic chronic kidney disease. Br ] Clin Pharmacol 2013;76:573-579.
4. Baylis C. Arginine, arginine analogs and nitric oxide production in chronic kidney disease. Nat Clin Pract Nephrol 2006;2:209-220.
5. Maguire JJ, Davenport AP. Endothelin receptors and their antagonists. Semin Nephrol 2015;35:125-136.
6. Reichetzeder C, Tsuprykov O, Hocher B. Endothelin receptor antagonists in clinical research-Lessons learned from preclinical and clinical kidney studies. Life Sci 2014; DOI: 10.1016/j.lfs.2014.02.025
7. Quaschning T, Voss F, Relle K, Kalk P, Vignon-Zellweger N, Pfab T, Bauer C, Theilig F, Bachmann S, Kraemer-Guth A, Wanner C, Theuring F, Galle J, Hocher: Lack of endothelial nitric oxide synthase promotes endothelin-induced hypertension: lessons from endothelin-1 transgenic/endothelial nitric oxide synthase knockout mice. J Am Soc Nephrol 2007;18:730-740.
8. Vignon-Zellweger N, Relle K, Kienlen E, Alter M, Seider P, Sharkovska J, Heiden S, Kalk P, Schwab K, Albrecht-Kiipper B, Theuring F, Stasch JP, Hocher B. Endothelin-1 overexpression restores diastolic function in eNOS knockout mice. J Hypertens 2011;29:961-970.
9. Hocher B, Thone-Reineke C, Rohmeiss P, Schmager F, Slowinski T, Burst V, Siegmund F, Quertermous T, Bauer C, Neumayer HH, Schleuning WD, Theuring F. Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J Clin Invest 1997;99:1380-1389.
10. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995;377:239-242.
11. Ott IM, Alter ML, von Websky K, Kretschmer A, Tsuprykov 0, Sharkovska Y, Krause-Relle K, Raila J, Henze A, Stasch JP, Hocher B.: Effects of stimulation of soluble guanylate cyclase on diabetic nephropathy in diabetic eNOS knockout mice on top of angiotensin II receptor blockade. PloS One 2012;7:e42623.
12. Illig T, Gieger C, Zhai G, Romisch-Margl W, Wang-Sattler R, Prehn C, Altmaier E, Kastenmuller G, Kato BS, Mewes HW, Meitinger T, de Angelis MH, Kronenberg F, Soranzo N, Wichmann HE, Spector TD, Adamski J, Suhre K.: A genome-wide perspective of genetic variation in human metabolism. Nat Genet 2010;42:137-141.
13. Romisch-Margl W, Prehn C, Bogumil R, Rohring C, Suhre K, Adamski J. Procedure for tissue sample preparation and metabolite extraction for high-Dhroughput targeted. Metabolomics 2012;8:133-142.
14. Guidance for Industry. Bioanalytical Method Validation. US Dep Health Hum Serv FaDA Cent Drug Eval Res CDER Cent Vet Med CVM 2001.
15. Suhre K, Shin SY, Petersen AK, Mohney RP, Meredith D, Wagele B, Altmaier E; CARDIoGRAM, Deloukas P, Erdmann J, Grundberg E, Hammond CJ, de Angelis MH, Kastenmüller G, Köttgen A, Kronenberg F, Mangino M, Meisinger C, Meitinger T, Mewes HW, Milburn MV, Prehn C, Raffler J, Ried JS, Romisch-Margl W, Samani NJ, Small KS, Wichmann HE, Zhai G, Illig T, Spector TD, Adamski J, Soranzo N, Gieger C. Human metabolic individuality in biomedical and pharmaceutical research. Nature 2011;477:54-60.
16. Horakova 0, Medrikova D, van Schothorst EM, Bunschoten A, Flachs P, Kus V, Kuda 0, Bardova K, Janovska P, Hensler M, Rossmeisl M, Wang-Sattler R, Prehn C, Adamski J, Illig X Keijer J, KopeckyJ. Preservation of metabolic flexibility in skeletal muscle by a combined use of n-3 PUFA and rosiglitazone in dietary obese mice. PloS One 2012;7:e43764.
17. Mullen W, Saigusa D, Abe X Adamski J, Mischak H. Proteomics and metabolomics as tools to unravel novel culprits and mechanisms of uremic toxicity: instrument or hype? Semin Nephrol 2014;34:180-190.
18. Goek ON, Prehn C, Sekula P, Romisch-Margl W, Doring A, Gieger C, Heier M, Koenig W, Wang-Sattler R, Illig X Suhre K, Adamski J, Köttgen A, Meisinger C. Metabolites associate with kidney function decline and incident chronic kidney disease in the general population. Nephrol Dial Transplant 2013;28:2131-2138.
19. Goek ON, Doring A, Gieger C, Heier M, Koenig W, Prehn C, Romisch-Margl W, Wang-Sattler R, Illig X Suhre K, Sekula P, Zhai G, Adamski J, Kottgen A, Meisinger C. Serum metabolite concentrations and decreased GFR in the general population. Am J Kidney Dis 2012;60:197-206.
20. Clarke NE, Turner AJ. Angiotensin-Converting Enzyme 2: The First Decade. IntJ Hypertens 2012;2012:1-12.
21. Nakagawa X Sato W, Glushakova 0, Heinig M, Clarke X Campbell-Dhompson M, Yuzawa Y, Atkinson MA, Johnson RJ, Croker B. Diabetic Endothelial Nitric Oxide Synthase Knockout Mice Develop Advanced Diabetic Nephropathy J Am Soc Nephrol 2007;18:539-550.
22. Muller V, Tain Y-L, Croker B, Baylis C. Chronic Nitric Oxide Deficiency and Progression of Kidney Disease after Renal Mass Reduction in the C57B16 Mouse. Am J Nephrol 2010;32:575-580.
23. Zhao HJ, Wang S, Cheng H, Zhang MZ, Takahashi X Fogo AB, Breyer MD, Harris RC. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol 2006;17:2664-2669.
24. Vignon-Zellweger N, Rahnenfuhrer J, Theuring F, Hocher B. Analysis of cardiac and renal endothelin receptors by in situ hybridization in mice. Clin Lab 2012;58:939-949.
25. Vignon-Zellweger N, Relle K, Rahnenfuhrer J, Schwab K, Hocher B, Theuring F. Endothelin-1 overexpression and endothelial nitric oxide synthase knock-out induce different pathological responses in the heart of male and female mice. Life Sci 2013; DOI: 10.1016/j.lfs.2013.12.003
26. Hocher B, Schwarz A, Reinbacher D, Jacobi J, Lun A, Priem F, Bauer C, Neumayer HH, Raschack M. Effects of endothelin receptor antagonists on the progression of diabetic nephropathy. Nephron 2001;87:161-169.
27. Hocher B, Schwarz A, SlowinskiT, Bachmann S, Pfeilschifter J, Neumayer HH, Bauer C. In-vivo interaction of nitric oxide and endothelin. J Hypertens 2004;22:111-119.
28. Jarad G, Miner JH. Update on the glomerular filtration barrier. Curr Opin Nephrol Hypertens 2009;18:226-232.
29. Suh JH, Miner JH. The glomerular basement membrane as a barrier to albumin. Nat Rev Nephrol 2013;9:470-477.
30. Chen YM, Zhou Y, Go G, Marmerstein JT, Kikkawa Y, Miner JH. Laminin (32 gene missense mutation produces endoplasmic reticulum stress inpodocytes. J Am Soc Nephrol 2013;24:1223-1233.
31. ChenYM, Miner JH. Glomerular basement membrane and related glomerular disease. Transl Res 2012;160:291-297.
32. Ellison JA, Velier JJ, Spera P, Jonak ZL, Wang X, Barone FC, Feuerstein GZ. Osteopontin and its integrin receptor alpha(v)beta3 are upregulated during formation of the glial scar after focal stroke. Stroke J Cereb Circ 1998;29:1698-1706; discussion 1707.
33. Alter ML, Kretschmer A, Von Websky K, TsuprykovO, Reichetzeder C, Simon A, Stasch JP, Hocher B. Early urinary and plasma biomarkers for experimental diabetic nephropathy Clin Lab 2012;58:659-671.
34. Liu Y, Bledsoe G, Hagiwara M, Shen B, Chao L, Chao J. Depletion of endogenous kallistatin exacerbates renal and cardiovascular oxidative stress, inflammation, and organ remodeling. Am J Physiol Renal Physiol 2012;303:F1230-1238.
35. Peng T, Hu Z, Wu L, Li D, Yang X. Correlation between endothelial dysfunction and left ventricular remodeling in patients with chronic kidney disease. Kidney Blood Press Res 2014;39:420-426.
36. Nakamura T, Kurashina T, Saito Y, Sumino H, Akuzawa N, Aizawa H, Sakamoto H, Ono Z, Nagai R. ET(A] receptor antagonist ameliorates nephrosclerosis and left ventricular hypertrophy induced in rat by prolonged inhibition of nitric oxide synthesis. Hypertens Res 1998;21:251-257.
37. Bouriquet N, Dupont M, Herizi A, Mimran A, Casellas D. Preglomerular sudanophilia in L-NAME hypertensive rats: involvement of endothelin. Hypertension 1996;27:382-391.
38. Ritter C, Zhang S, Finch JL, Liapis H, Suarez E, Ferder L, Delmez J, Slatopolsky E. Cardiac and renal effects of atrasentan in combination with enalapril and paricalcitol in uremic rats. Kidney Blood Press Res 2014;39:340-352.
39. Guder WG, Wagner S. The role of the kidney in carnitine metabolism. J Clin Chem Clin Biochem 1990;28:347-350.
40. Violante S, Ijlst L, Ruiter J, Koster J, van Lenthe H, Duran M, de Almeida IT, Wanders RJ, Houten SM, Ventura FV. Substrate specificity of human carnitine acetyltransferase: Implications for fatty acid and branched-chain amino acid metabolism. Biochim Biophys Acta 2013;1832:773-779.
41. Violante S, Ijlst L, Ruiter J, Koster J, van Lenthe H, Duran M, de Almeida IT, Wanders RJ, Houten SM, Ventura FV. Endothelin-1 Induces a Glycolytic Switch in Pulmonary Arterial Endothelial Cells via the Mitochondrial Translocation of Endothelial NO Synthase. Am J Respir Cell Mol Biol 2014; DOI: 10.1165/rcmb.2013-0187OC\
42. Gomez-Amores L, Mate A, Miguel-Carrasco JL, Jimenez L, Jos A, Camean AM, Revilla E, Santa-Maria C, Vazquez CM. L-carnitine attenuates oxidative stress in hypertensive rats. J Nutr Biochem 2007;18:533-540.
43. Zambrano S, Blanca AJ, Ruiz-Armenta MV, Miguel-Carrasco JL, Revilla E, Santa-Maria C, Mate A, Vazquez CM. The renoprotective effect of L-carnitine in hypertensive rats is mediated by modulation of oxidative stress-related gene expression. Eur J Nutr 2013;52:1649-1659.
44. Couloubaly S, Delomenie C, Rousseau D, Paul JL, Grynberg A, Pourci ML. Fatty acid incorporation in endothelial cells and effects on endothelial nitric oxide synthase. Eur J Clin Invest 2007;37:692-699.
45. Lupo A, Bernich P, Fabris A, Zanni P, Trevisan MT, Ferrari S, Bassi A, Girelli D, Olivieri 0, Maschio G. Cell membrane lipid composition in CAPD patients. Adv Perit Dial Conf Perit Dial 1990;6:230-232.
46. Galli F, Varga Z, Balla J, Ferraro B, Canestrari F, Floridi A, Kakuk G, Buoncristiani U. Vitamin E, lipid profile, and peroxidation in hemodialysis patients. Kidney Int 2001;78:S148-154.
47. Botham KM, Wheeler-Jones CPD. Postprandial lipoproteins and the molecular regulation of vascular homeostasis. Prog Lipid Res 2013;52:446-464.
48. Zucker SN, Fink EE, Bagati A, Mannava S, Bianchi-Smiraglia A, Bogner PN, Wawrzyniak JA, Foley C, Leonova KI, Grimm MJ, Moparthy K, Ionov Y, Wang J, Liu S, Sexton S, Kandel ES, Bakin AV, Zhang Y, Kaminski N, Segal BH, Nikiforov MA. Nrf2 Amplifies Oxidative Stress via Induction of Klf9. Mol Cell 2014;53:916-928.
49. Looft-Wilson RC, Ashley BS, Billig JE, Wolfert MR, Ambrecht LA, Bearden SE. Chronic diet-induced hyperhomocysteinemia impairs eNOS regulation in mouse mesenteric arteries. Am J Physiol Regul Integr Comp Physiol 2008;295:R59-66.
50. Hardeman D, van den Bosch H. Topography of ether phospholipid biosynthesis. Biochim Biophys Acta 1989;1006:1-8.
51. Andrew PJ, Mayer B. Enzymatic function of nitric oxide synthases. Cardiovasc Res 1999;43:521-531.
52. Mohan S, Wu C-C, Shin S, Fung H-L. Continuous exposure to L-Arginine induces oxidative stress and physiological tolerance in cultured human endothelial cells. Amino Acids 2012:1179-1188.